For the first time ever, gene therapy is being used to treat an "ultra-rare disease" in a young Toronto boy.

Michael Pirovolaki has hereditary spastic paraplegia type 50, otherwise known as SPG50 — a neurodegenerative disease so rare, it's believed Michael may be the only child in Canada afflicted by the condition.

As Caryn Lieberman reports, his family raised more than $3 million to pay for the research and development of a treatment to help save their son.

For more info, please go to [ Ссылка ]

Subscribe to Global News Channel HERE: [ Ссылка ]
Like Global News on Facebook HERE: [ Ссылка ]
Follow Global News on Twitter HERE: [ Ссылка ]
Follow Global News on Instagram HERE: [ Ссылка ]
#GlobalNews #SPG50 #Health

свернуть